TABLE 5.
UTILITY VALUES OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION (ARMD) AND RESPONDENT GROUPS
| ARMD GROUPINGS* | UTILITY VALUE (SD; 95% CI) | PVALUE | |||
|---|---|---|---|---|---|
| PATIENTS WITH ARMD†2,3(N = 82) | COMMUNITY3(N = 142) | CLINICIANS3(N = 62) | OPHTHALMOLOGISTS22(N = 46) | ||
| Mild (20/20 to 20/40) | 0.83 (.19; .77–.89) (n = 42) | 0.96 (.06; .95–.97) (n = 142) | 0.93 (.10; .90–.96) (n = 62) | 0.98 (.03; .97–.99) (n = 46) | <.001* |
| Moderate (20/50 to 20/100) | 0.68 (.21; .59–.77) (n = 22) | 0.92 (.10; .90–.94) (n = 142) | 0.88 (.12; .85–.91) (n = 62) | 0.89 (.10; .86–.92) (n = 46) | <.001* |
| Severe (20/200 or worse) | 0.47 (.18; .39–.55) (n = 18) | 0.86 (.15; .84–.88) (n = 142) | 0.82 (.14; .78–.86) (n = 62) | 0.73 (.19; .68–.78) (n = 46) | <.001* |
| Very severe (≤ 20/800) | 0.40 (.13; .31–.49) (n = 8) | NA | NA | 0.67 (.18; .62–.72) (n = 46) | <.001* |
ARMD = age-related macular degeneration; NA = not available.
*
Snellen visual acuity ranges for the better-seeing eye are listed below the Mild, Moderate, Severe, and Very severe groupings.
†
The patient values are significantly different from those of the community, clinician, and ophthalmologist groups in all categorical ARMD groupings, by one-way analysis of variance (P <.0001.)